---
$id: https://graph.org.ai/products/commodity/51111910
$type: Product
source: UNSPSC
code: "51111910"
title: "Paclitaxel poliglumex"
class: "51111900"
classTitle: "Natural antineoplastic products"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Paclitaxel poliglumex

**UNSPSC Code**: 51111910
**Class**: [Natural antineoplastic products](Natural antineoplastic products.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a taxane compound and paclitaxel preparation, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TQ64FZ98ZN. European Medicines Agency schedules Paclitaxel poliglumex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27755. Paclitaxel poliglumex generally arises in the molecular formula C10H16N2O7(C52H56N2O16)N(C5H7NO3)N. The term PACLITAXEL POLIGLUMEX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, no. 3, 2004, list 52.) Most nations schedule paclitaxel poliglumex under HS 39089000 and SITC 57539. As of Q4 2014, PACLITAXEL POLIGLUMEX remains the US FDA Preferred Term for this commodity. Paclitaxel poliglumex bears US NLM identifiers UMLS ID C1702776 and NCI Concept Code C1795. SMILES: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)OC(=O)CCC(C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)N)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C.

